Mirum Pharmaceuticals logo

Mirum Pharmaceuticals Share Price (NASDAQ: MIRM)

$73.88

-1.65

(-2.18%)

Last updated on

Check the interactive Mirum Pharmaceuticals Stock chart to analyse performance

Mirum Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$73.16
    Today's High:$75.60

    Day's Volatility :3.23%

  • 52 Weeks Low:$36.86
    52 Weeks High:$75.63

    52 Weeks Volatility :51.26%

Mirum Pharmaceuticals Stock Returns

PeriodMirum Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
60.58%
3.6%
0.0%
6 Months
60.51%
-7.7%
0.0%
1 Year
78.7%
-12.6%
0.0%
3 Years
190.63%
9.5%
-4.7%

Mirum Pharmaceuticals Inc Key Stats

Check Mirum Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$75.53
Open
$75.59
Today's High
$75.6
Today's Low
$73.16
Market Capitalization
$3.8B
Today's Volume
$1.1M
52 Week High
$75.625
52 Week Low
$36.8591
Revenue TTM
$429.2M
EBITDA
$-32.9M
Earnings Per Share (EPS)
$-1.21
Profit Margin
-13.65%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-24.19%

Stock Returns calculator for Mirum Pharmaceuticals Stock including INR - Dollar returns

The Mirum Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mirum Pharmaceuticals investment value today

Current value as on today

₹1,76,660

Returns

₹76,660

(+76.66%)

Returns from Mirum Pharmaceuticals Stock

₹71,376 (+71.38%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Mirum Pharmaceuticals Stock

122%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Mirum Pharmaceuticals Stock from India on INDmoney has increased by 122% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mirum Pharmaceuticals Inc

  • Name

    Holdings %

  • HHG PLC

    10.46%

  • BlackRock Inc

    6.67%

  • Bvf Inc

    5.52%

  • Vanguard Group Inc

    5.12%

  • Eventide Asset Management, LLC

    5.05%

  • Novo A/S

    3.00%

Analyst Recommendation on Mirum Pharmaceuticals Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Mirum Pharmaceuticals(by analysts ranked 0 to 5 stars)

Mirum Pharmaceuticals Share Price Target

What analysts predicted

Upside of 5.95%

Target:

$78.27

Current:

$73.88

Mirum Pharmaceuticals share price target is $78.27, a slight Upside of 5.95% compared to current price of $73.88 as per analysts' prediction.

Mirum Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 month, MIRM stock has moved up by 44.4%
  • Increasing Revenue

    Revenue is up for the last 6 quarters, 69.22M → 127.78M (in $), with an average increase of 11.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -23.79M → -5.86M (in $), with an average increase of 106.3% per quarter

Mirum Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Mirum Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mirum Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Mirum Pharmaceuticals Inc logo
42.84%
60.51%
78.7%
190.63%
209.0%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

Mirum Pharmaceuticals Dividend announcements

  • Mirum Pharmaceuticals Earnings

    Mirum Pharmaceuticals’s price-to-earnings ratio stands at None

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.
Organization
Mirum Pharmaceuticals
Employees
349
CEO
Mr. Christopher Peetz
Industry
Health Technology

Key Management of Mirum Pharmaceuticals Inc

NameTitle
Mr. Christopher Peetz
CEO & Director
Mr. Peter Radovich M.B.A., Ph.D.
COO & President
Mr. Eric H. Bjerkholt M.B.A., M.S.
Chief Financial Officer
Dr. Joanne M. J. Quan M.D.
Chief Medical Officer
Dr. Jean-Luc Girardet Ph.D.
Chief Technical Officer
Mr. Andrew McKibben
Senior Vice President, Strategic Finance & Investor Relations
Mr. Paul K. Ross
Chief Compliance Officer
Mr. Douglas T. Sheehy J.D.
Chief Legal Officer
Ms. Erin Campany
Chief People Officer
Ms. Lara Longpre MBA, MSC
Chief Development Officer

Important FAQs about investing in MIRM Stock from India :

What is Mirum Pharmaceuticals share price today?

Mirum Pharmaceuticals share price today is $73.88 as on at the close of the market. Mirum Pharmaceuticals share today touched a day high of $75.60 and a low of $73.16.

What is the 52 week high and 52 week low for Mirum Pharmaceuticals share?

Mirum Pharmaceuticals share touched a 52 week high of $75.63 and a 52 week low of $36.86. Mirum Pharmaceuticals stock price today i.e. is closed at $73.88, lower by 2.31% versus the 52 week high.

How to invest in Mirum Pharmaceuticals Stock (MIRM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mirum Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mirum Pharmaceuticals Shares that will get you 0.0203 shares as per Mirum Pharmaceuticals share price of $73.88 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mirum Pharmaceuticals Stock (MIRM) from India?

Indian investors can start investing in Mirum Pharmaceuticals (MIRM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Mirum Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Mirum Pharmaceuticals share’s latest price of $73.88 as on August 30, 2025 at 1:29 am IST, you will get 0.1354 shares of Mirum Pharmaceuticals. Learn more about fractional shares .

What are the returns that Mirum Pharmaceuticals has given to Indian investors in the last 5 years?

Mirum Pharmaceuticals stock has given 209.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?